Why the study?
Do chronotherapeutic formulations and long-acting antihypertensive agents improve 24-hour blood pressure control and attenuate the early morning blood pressure surge in hypertensive patients?
Population
Hypertensive patients and susceptible individuals at risk for cardiovascular events
Design
Review
Authors
Loading...
Supports chronotherapy for morning BP control; leaves open dedicated outcome trials before practice change.
Do chronotherapeutic formulations and long-acting antihypertensive agents improve 24-hour blood pressure control and attenuate the early morning blood pressure surge in hypertensive patients?
Chronotherapeutic and long-acting antihypertensive agents are recommended to provide 24-hour blood pressure control and mitigate the early morning surge in blood pressure, which is associated with increased cardiovascular risk.
William B. White (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: